Zeria Pharmaceutical Co Ltd banner

Zeria Pharmaceutical Co Ltd
TSE:4559

Watchlist Manager
Zeria Pharmaceutical Co Ltd Logo
Zeria Pharmaceutical Co Ltd
TSE:4559
Watchlist
Price: 2 191 JPY -3.48% Market Closed
Market Cap: ¥96.6B

Zeria Pharmaceutical Co Ltd
Non-Reccuring Items

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Zeria Pharmaceutical Co Ltd
Non-Reccuring Items Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Non-Reccuring Items CAGR 3Y CAGR 5Y CAGR 10Y
Zeria Pharmaceutical Co Ltd
TSE:4559
Non-Reccuring Items
-¥15.5m
CAGR 3-Years
68%
CAGR 5-Years
N/A
CAGR 10-Years
27%
Takeda Pharmaceutical Co Ltd
TSE:4502
Non-Reccuring Items
-¥133.1B
CAGR 3-Years
-41%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Daiichi Sankyo Co Ltd
TSE:4568
Non-Reccuring Items
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Otsuka Holdings Co Ltd
TSE:4578
Non-Reccuring Items
¥23B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Chugai Pharmaceutical Co Ltd
TSE:4519
Non-Reccuring Items
-¥12.6B
CAGR 3-Years
-170%
CAGR 5-Years
-67%
CAGR 10-Years
-70%
Astellas Pharma Inc
TSE:4503
Non-Reccuring Items
¥4.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Zeria Pharmaceutical Co Ltd
Glance View

Market Cap
96.6B JPY
Industry
Pharmaceuticals

Zeria Pharmaceutical Co., Ltd. engages in the manufacture, sale, import and export of pharmaceutical products. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 1,690 full-time employees. The firm operates in two business segments. The Ethical Drug segment is engaged in the research, development, manufacture and sale of ethical drugs. The Consumer Healthcare segment is engaged in the manufacture, purchase and sale of over-the-counter (OTC) drugs, health foods, quasi drugs and cosmetics related to self-medication. The others include insurance agency business and real estate business, as well as various maintenance business such as purchasing and sale of promotional materials.

Intrinsic Value
3 809.44 JPY
Undervaluation 42%
Intrinsic Value
Price ¥2 191

See Also

What is Zeria Pharmaceutical Co Ltd's Non-Reccuring Items?
Non-Reccuring Items
-15.5m JPY

Based on the financial report for Dec 31, 2025, Zeria Pharmaceutical Co Ltd's Non-Reccuring Items amounts to -15.5m JPY.

What is Zeria Pharmaceutical Co Ltd's Non-Reccuring Items growth rate?
Non-Reccuring Items CAGR 10Y
27%

The average annual Non-Reccuring Items growth rates for Zeria Pharmaceutical Co Ltd have been 68% over the past three years , and 27% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett